Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Ken‐ichiro Seino, Haruka Wada et al.|iScience|2020Cited by 26
Interleukin-34 contributes to poor prognosis in triple-negative breast cancerNabeel Kajihara, K. Seino, Fumihito Kitagawa et al.|Breast Cancer|2020Cited by 21
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint BlockadeNaoki Hama, Ken‐ichiro Seino, Muhammad Baghdadi et al.|iScience|2022Cited by 1